FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
Public Health,Health,Vaccines,Life During Covid-19,Coronavirus,Trump Administration,Robert F Kennedy Jr,FDA
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.
Prasad, a professor at the University of California San Francisco, became a harsh critic of the governmentβs response and its vaccine policies during the Covid-19 pandemic. He replaces Dr. Peter Marks, who helped lead the division for 13 years and shaped the Operation Warp Speed effort to rapidly develop Covid-19 vaccines and treatments.
Related Coverage
AllSides Picks
Headline Roundup
US Loses Measles Elimination Status After 26 Years
November 17th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
Affordable Care Act
Story of the Week
Technology Outages Affect Banking, Transportation, and Tech Sectors
AllSides Staff
November 19th, 2026